Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Vulcan Value Partners - Large Cap. This analysis is provided for institutional research purposes only and is not investment advice.
"Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict value discipline through strategic capital reallocation."
In Q2 2025, Vulcan Value Partners navigated tariff-driven market volatility, leveraging sudden price drops to purchase high-conviction companies at steep discounts. Across composites, they purchased or added to positions in UnitedHealth Group (following a >50% decline driven by guidance withdrawal and CEO transition), IQVIA Holdings, and Forterra plc. These moves were funded by trimmings/exits of companies like Carlyle Group, Heineken, Rentokil, Dun & Bradstreet, and Partners Group. Key contributors to performance during the quarter included Microsoft, Ares Management, ISS A/S, and Littelfuse.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Growth Outlook
Market outlook remains above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Risk Appetite
Risk appetite posture is above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Forward Guidance
Forward guidance signal: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Language Signal
Tone analysis indicates above average conviction language: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Time Horizon
Investment time horizon reflects a high conviction orientation. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
